EVO Stock Analysis: Buy, Sell, or Hold?
EVO - Evotec SE American Depositary Shares
$3.07
0.02 (0.66%)
▲
5d:
-0.65%
30d:
+17.18%
90d:
-13.03%
BUY
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When EVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EVO shows positive signals but monitor for confirmation. Market pricing in 42.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: EVO shows positive signals but monitor for confirmation. Market pricing in 42.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.58
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.67
68.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EVO is currently trading at $3.07, which is considered fair relative to its 30-day fair value range of $2.67 to $3.24. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.6) compared to its historical average (51.3). Remarkably, the market is currently pricing in an annual earnings decline of 42.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EVO is in a downtrend. Immediate support is located at $2.90, while resistance sits at $3.30.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.26 (+71.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EVO is in a downtrend. Immediate support is located at $2.90, while resistance sits at $3.30.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.26 (+71.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.67 -
$3.24
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.4% below Wall St target ($5.26)
Trading Range Analysis
30-Day Trading Range
$2.67 -
$3.24
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.90
Resistance Level
$3.30
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.59
Wall Street Target
$5.26
(+71.4%)
Revenue Growth (YoY)
14.5%
Profit Margin
-13.1%
Valuation Discount vs History
-42.8% cheaper
PE vs Historical
9.6 vs 51.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-42.8%
(market-implied from PE analysis)
1-Year Target
$2.76
(-10%)
2-Year Target
$2.49
(-19%)
3-Year Target
$2.24
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→51)
$11.97
(+290%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 540.0%)
$23.70
(+672%)
Base:
(SPY PE: 9.6, Growth: 540.0%)
$10.36
(+238%)
Bear:
(PE: 8.2, Growth: 540.0%)
$8.81
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.6 to 51.3
Stabilization Target:
$16.42
(+434.7%)
PE Expansion Potential:
+434.7%
Share & Embed Analysis
Last updated: May 08, 2026 5:21 PM ET
Data refreshes hourly during market hours. Next update: 6:21 PM
Data refreshes hourly during market hours. Next update: 6:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$186 | 66 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$96 | 65 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$149 | 52 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 54 HOLD |
